
ABOUT MILTENYI BIOTEC
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,500 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
FEATURED CONTENT
-
Syngeneic mouse tumor models are crucial for immunotherapy research, but variability in TILs and nonspecific binding complicate analysis. Discover how blocking reagents help but make the process more labor-intensive.
-
Investigate how CAR-T cells treat hematopoietic malignancies as well as the correlation between flow cytometry and qPCR in monitoring CAR-T cell therapy, which validates their combined use for accurate assessment.
-
Flow cytometric phenotyping is crucial for immunotherapy to enable precise immune monitoring. Discover how standardized assays with an 8-color cocktail enhance the understanding of tumor immunity and therapeutic impacts.
-
Explore an assay kit that simplifies handling with a methylcellulose-free medium and clear flow cytometric readout, which enhances automation and high-throughput sample acquisition for versatile research.
-
In-process and quality control ensure consistent manufacturing of gene-engineered hematopoietic stem cells. Discover an engineering process that enhances production through viral transduction and integrated sampling pouches.
-
Discover how innovative in vitro assays for CAR-T cells can enhance therapeutic outcomes by providing detailed insights into their properties and behaviors throughout pre-clinical and clinical development.
-
CAR-T cell therapy shows unprecedented efficacy in targeting cancer. Explore a device that simplifies the complex manufacturing process and enables automated CAR-T cell generation to ensure quality control and phenotyping.
-
Discover a system that automates CAR-T cell production using flow cytometry and analyzers for precise monitoring as well as learn about the sample preparation, instrument setup, and data analysis.
-
Many drug development platforms focus solely on cost reduction or improved process efficiency, offering few, if any, solutions to bolster biological performance.
-
Gain insights and key recommendations from industry and regulatory experts on navigating assay validation for cell and gene therapy throughout the product development lifecycle.
-
Flow cytometry compensation is critical, for it directly impacts data accuracy and quality. Here, we share eight tips to improve compensation in multicolor flow experiments.
-
Learn the 4 physical conditions that occur during droplet sorting, which may keep your cells from being happy.
-
Here, we demonstrate the capacity of a specific bench top sorter to allow for completely aseptic sorting conditions by using the system to sort cancer antigen-specific cytotoxic T cells out of PBMCs.
-
Isolating fully functional CAR T cells requires high quality cell separation. See how we successfully and efficiently isolated CD19 CAR T cells with the MACSprep™ CD19 CAR MicroBead Kit, human.
-
Learn how the knowledge generated by a deep and thorough analysis of chemokine receptors on natural killer (NK) cells can be helpful to scientists studying certain cancers and diseases.
-
Here, we describe the multicolor flow cytometry analysis necessary to study natural killer (NK) cell phenotype and the function of isolated NK cells from whole blood.
-
Here, we show an automated experimental setup for human CD34+ HSC enrichment from umbilical cord blood for the successful generation of humanized mouse models.
-
Research is being done to study a new method for isolating TILs from human colon tumor xenografts that could be more efficient and effective than traditional methods.
-
Explore results from a study that utilized an in vivo model to assess the antibody-dependent cellular cytotoxicity (ADCC) activity of antibodies to clear HIV-infected cells.
-
High-quality automated cell isolation and consistent cell culture and stimulation conditions are required for successful immuno-oncology studies. See how CD8+ T cells and XP-DCs were isolated using MACS® technology.
CONTACT INFORMATION
Miltenyi Biotec
12740 Earhart Ave.
Auburn, CA 95602
UNITED STATES